Dr. Shyam Bishen is the US Regional Director of Life Sciences Partnerships at the Bill & Melinda Gates Foundation in Seattle. Before this, he was Head of Emerging Markets Strategy and Commercial Development as well as General Manager of Biosimilars Business Unit at Merck, based out of the company headquarters in Whitehouse Station, New Jersey. Prior to joining Merck in early 2011, he was Vice President of Corporate Development at Ranbaxy based in Princeton, New Jersey. Before moving to Ranbaxy in 2005, Dr. Bishen worked with Pfizer/Pharmacia in New Jersey and Schein in New York.
Currently, Dr. Bishen is responsible for leading the foundation’s strategic industry engagements throughout the US region. Before moving to this role, Dr. Bishen headed up Emerging Markets Strategy, Commercial Development, and Biosimilars Business at Merck for close to 4 years. At Ranbaxy, Dr. Bishen was leading corporate strategy, business development, and licensing. Dr. Bishen worked at Schein Inc., as Vice President of Business Development where he was responsible for leading the pharmaceutical business development initiatives including biologics and vaccines. At Pfizer/ Pharmacia, he was Director of Corporate Strategy, wherein he led strategic planning and business development programs.
Before joining the Pharma industry, Dr. Bishen was in academia and worked on anticancer research as an Assistant Professor at the Medical University of South Carolina in Charleston. He has published over 20 research papers and received several US patents in drug discovery and development. Dr. Bishen is qualified with Doctorate in Chemistry from the University of Newcastle. He also holds a Masters in Business Administration from Washington University in St. Louis.